Windtree Therapeutics
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2600 Kelly Rd Ste 100, Warrington, Penns...Phone Number
(215) 488-9300Website
www.windtreetx.comRevenue
<$5 MillionStock Symbol
WINTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Windtree Therapeutics
Founded in 1992, Windtree Therapeutics is a specialty biotechnology company focused on advancing respiratory critical care through the development of technologies, including those that address persistent unmet medical needs through their proprietary KL4 surfactant technology and aerosolizing respiratory delivery medicines.Explore more
Windtree Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Windtree Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Windtree Therapeutics
Check if Windtree Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Windtree Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Windtree Therapeutics recently announced quarterly report
Check out if Windtree Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Windtree Therapeutics has new funding data
Product Launch: Get notified when Windtree Therapeutics launches new products
Windtree Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Windtree Therapeutics
Compare insights from companies similar to Windtree Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Windtree Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Windtree Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Windtree Therapeutics.
Windtree Therapeutics financials insights
Gather financial insights about Windtree Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Debt
$12.9M
2025
Debt
$500M
Windtree Therapeutics Tech Stack
A closer look at the technologies used by Windtree Therapeutics
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Person-Based
Person-Based
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Windtree Therapeutics News & Media
Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space
Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisionsWindtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee
The Company has a global license agreement for the acute pulmonary that could pay up to $78.9 million in development, regulatory and commercial milestones plus low double digit royaltiesWindtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate
Windtree has a total of 59 issued or allowed patents and 17 pending patents for Istaroxime and its SERCA2a activatorsWindtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company
Windtree and TESI signed a letter of intent for a combination of cash and securities of TESI to be paid to Windtree
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Windtree Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 1992, Windtree Therapeutics is a specialty biotechnology company focused on advancing respiratory critical care through the development of technologies, including those that address persistent unmet medical needs through their proprietary KL4 surfactant technology and aerosolizing respiratory delivery medicines.... Read More
